(Q34083698)

30 July 2017

0 references

Treatment of chronic headache with antidepressants: a meta-analysis (English)

1 reference

30 July 2017

0 references

1 reference

1 reference

Tomkins GE

1

1 reference

30 July 2017

Jackson JL

2

1 reference

30 July 2017

O'Malley PG

3

1 reference

30 July 2017

Balden E

4

1 reference

30 July 2017

Santoro JE

5

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

American Journal of Medicine

30 July 2017

1 reference

30 July 2017

111

1 reference

30 July 2017

54-63

1 reference

30 July 2017

1

1 reference

Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey

30 July 2017

2 references

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Burden of migraine in the United States: disability and economic costs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Transformed migraine, analgesic rebound, and other chronic daily headaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

TREATMENT OF CHRONIC TENSION HEADACHE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Transformation of episodic migraine into daily headache: analysis of factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Bias in meta-analysis detected by a simple, graphical test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

A note on graphical presentation of estimated odds ratios from several clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Meta-analysis in clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

The file drawer problem and tolerance for null results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Double-blind crossover comparison of bc-105, methysergide and placebo in the prophylaxis of migraine headache

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Efficacy of nimodipine in comparison with pizotifen in the prophylaxis of migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Ritanserin is not effective in tension headache

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Amitriptyline in migraine prophylaxis: Changes in pattern of attacks during a controlled clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Migraine and the noradrenergic control of vasomotricity: a study with alpha-2 stimulant and alpha-2 blocker drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

BC-105 a new preparation for the interval treatment of migraine--a double blind evaluation compared with a placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Femoxetine in the prophylaxis of migraine--a randomised comparison with placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Clomipramine and metoprolol in migraine prophylaxis--a double-blind crossover study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

A Double Blind Trial for the Clinical Management of Psychogenic Headache

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Doxepin in the prophylactic treatment of mixed 'vascular' and tension headache

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Placebo, 1-Isopropylnoradrenochrome-5-Monosemicarbazono and Pizotifen in Migraine Prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Appraisal of BC-105 in migraine prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Chronic tension headache--treated with amitriptyline--a double-blind study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

A trial of opipramol in the treatment of migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Pizotifen (BC 105) in migraine prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Sanomigran for Migraine Prophylaxis; Controlled Multicenter Trial in General Practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Amitriptyline in Migraine Prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Prophylaxis of migraine and mixed headache. A randomized controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

So-called "tension headache"--the response to a 5-HT uptake inhibitor: femoxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Maprotiline in chronic tension headache: a double-blind cross-over study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

A randomized general practice group-comparative study of femoxetine and placebo in the prophylaxis of migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Migraine prophylaxis. A comparison of propranolol and amitriptyline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Amitriptyline in the treatment of headache in patients with Parkinson's disease: a double-blind placebo-controlled study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

A comparative study of naproxen sodium, pizotyline and placebo in migraine prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Fluoxetine prophylaxis of migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Double-blind trial of fluoxetine: chronic daily headache and migraine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Chronic tension-type headache: amitriptyline reduces clinical headache-duration and experimental pain sensitivity but does not alter pericranial muscle activity readings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Efficacy and tolerability of amitriptylinoxide in the treatment of chronic tension-type headache: a multi-centre controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Studies to assess if pizotifen prophylaxis improves migraine beyond the benefit offered by acute sumatriptan therapy alone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Clomipramine and Mianserin in the Treatment of Chronic Tension Headache. A Double-Blind, Controlled Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Chronic tension-type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Effect sizes for interpreting changes in health status.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Clinical predictors of mental disorders among medical outpatients. Validation of the "S4" model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Depressive and anxiety disorders in patients presenting with physical complaints: clinical predictors and outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Physical symptoms in primary care. Predictors of psychiatric disorders and functional impairment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Relationship of headaches to depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Antidepressants and serotonin neurons of the raphe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

Mianserin in the prophylaxis of migraine: a double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900762-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(01)00762-8

1 reference

30 July 2017

1 reference